Second Primary Tumours in Long-Term Survivors of Small-Cell Lung Cancer and Smoking Cessation
Author Information
Author(s): M Kawahara, S Ushijima, T Kamimori, N Kodama, M Ogawara, K Matsui, N Masuda, M Takada, T Sobue, K Furuse
Primary Institution: National Kinki Central Hospital for Chest Diseases
Hypothesis
Does smoking cessation after treatment for small-cell lung cancer reduce the risk of developing second primary tumours?
Conclusion
Patients with small-cell lung cancer who survive more than 2 years have a significantly increased risk of developing a second primary tumour, but quitting smoking after treatment is associated with a decreased risk.
Supporting Evidence
- 70 out of 980 patients survived cancer-free for more than 2 years.
- 15 of the 70 disease-free survivors developed a second primary tumour.
- Patients who continued smoking had a 5.4 times higher risk of developing a second primary tumour.
Takeaway
If you survive lung cancer for more than two years, you might get another cancer, but if you stop smoking, your chances of getting that second cancer go down.
Methodology
The study analyzed 980 patients with small-cell lung cancer treated with chemotherapy and/or radiotherapy, tracking their smoking habits and the occurrence of second primary tumours.
Potential Biases
Potential bias in smoking status reporting as it was obtained from patients, relatives, or medical records.
Limitations
The study may have limitations due to the small number of patients who developed second primary tumours and the reliance on self-reported smoking status.
Participant Demographics
Patients were treated at two hospitals in Japan, with a median follow-up of 6.7 years.
Statistical Information
P-Value
0.03
Confidence Interval
95% CI 2.0-5.9
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website